David A. Spellman, SVP, CFO and Treasurer at Akebia Therapeutics, Inc. (AKBA), sold 7,210 shares at $0.88 ($6K) on 2023-03-01, disclosed to the SEC on 2023-03-03.
Open-market sale of $6k AKBA by SVP, CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.88 | 810 | $713 | 11.2% |
| 2 | $0.88 | 6,400 | $6K | 88.8% |
| Total | $0.88 avg | 7,210 | $6K | 100% |
| Filing → |
| AKBA | SELL | 2022-03-02 | $18K | — | Filing → |
| AKBA | SELL | 2021-04-01 | $3K | — | Filing → |